[1]
|
Reich A. Interleukin-17 blockade in generalized pustular psoriasis-new hope for severely ill patients [J]. Br J Dermatol, 2017, 176: 572-573. doi: 10.1111/bjd.14987 |
[2]
|
Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis [J]. N Engl J Med, 2011, 365: 620-628. doi: 10.1056/NEJMoa1013068 |
[3]
|
Jordan CT, Cao L, Roberson ED, et al. PSORS2 is due to mutations in CARD14 [J]. Am J Hum Genet, 2012, 90: 784-795. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=e523f113631af97f465990c9cd244b11 |
[4]
|
Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist [J]. J Invest Dermatol, 2013, 133: 2514-2521. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=77c0318cba979d3142142b831c593252 |
[5]
|
Korber A, Mssner R, Renner R, et al. Mutations in IL36RN in patients with generalized pustular psoriasis [J]. J Invest Dermatol, 2013, 133: 2634-2637. doi: 10.1038/jid.2013.214 |
[6]
|
Sharma U, Rando OJ. Metabolic inputs into the epigenome [J]. Cell Metab, 2017, 25: 544-558. doi: 10.1016/j.cmet.2017.02.003 |
[7]
|
Chen SH, Lv QL, Hu L. DNA methylation alterations in the pathogenesis of lupus [J]. Clin Exp Immunol, 2017, 187: 185-192. doi: 10.1111/cei.12877 |
[8]
|
桂欣钰, 晋红中.异常DNA甲基化与免疫性皮肤病[J].协和医学杂志, 2017, 8: 46-49. doi: 10.3969/j.issn.1674-9081.2017.03.009 |
[9]
|
Elhamamsy AR. Role of DNA methylation in imprinting disorders: an updated review [J]. J Assist Reprod Genet, 2017, 34:549-562. doi: 10.1007/s10815-017-0895-5 |
[10]
|
Gowher H, Liebert K, Hermann A, et al. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA- (cytosine-C5)-methyltransferases by DNMT3L [J]. J Biol Chem, 2005, 280: 13341-13348. doi: 10.1074/jbc.M413412200 |
[11]
|
Lopez-Serra L, Esteller M. Proteins that bind methylated DNA and human cancer: reading the wrong words [J]. Br J Cancer, 2008, 98: 1881-1885. doi: 10.1038/sj.bjc.6604374 |
[12]
|
Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity [J]. Arch Dermatol Res, 2003, 295 Suppl 1: S43-S54. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=6cfa5fec4d91fd205e6df0a095ddfacc |
[13]
|
Onoufriadis A, Simpson MA, Pink AE, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis [J]. Am J Hum Genet, 2011, 89: 432-437. doi: 10.1016/j.ajhg.2011.07.022 |
[14]
|
Sugiura K, Muto M, Akiyama M. CARD14c.526G4C(p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort [J]. J Invest Dermatol, 2014, 134: 1755-1757. doi: 10.1038/jid.2014.46 |
[15]
|
Bestor TH. The DNA methyltransferases of mammals [J]. Hum Mol Genet, 2000, 9: 2395-2402. doi: 10.1093/hmg/9.16.2395 |
[16]
|
Tajima S, Suetake I, Takeshita K, et al. Domain structure of the DNMT1, DNMT3a, and DNMT3b DNA methyltrans-ferases [J]. Adv Exp Med Biol, 2016, 945: 63-86. http://europepmc.org/abstract/med/27826835 |
[17]
|
Wood KH, Johnson BS, Welsh SA, et al. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions [J]. Epigenomics, 2016, 8: 455-473. doi: 10.2217/epi-2015-0004 |
[18]
|
Pandey S, Pruitt K. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon and prostate [J]. Biochem Cell Biol, 2017, 95: 368-378. doi: 10.1139/bcb-2016-0154 |